IL6 and COVID-19: In our cohort, the serum levels of IL-6 and SP-D were elevated dramatically in severe patients, suggesting that SP-D, together with IL-6, may participate in the complex immune dysregulation process and contribute to the pathogenesis of severe COVID-19.